TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
LBRX

LB Pharmaceuticals Inc

Healthcare · Biotechnology

37.80$ -3.5% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow LBRX
Line item 2022 2023 2024 2025
– – – –
– +100.0% +2,175.0% +252.7%
– -31.6% +971.5% +32.6%
– -1,626.7% – -512.0%
– – +2,976.0% -93.2%
– -22,872.4% – -271.7%
– -97.1% -100.0% –
– +46.7% +13.8% +689.7%
– -131.6% – +2,573.8%
– – – –

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?